日本精准医疗市场报告（按产品、技术、应用（肿瘤学、中枢神经系统、免疫学、呼吸医学、感染等）、最终用户和地区）2025 年至 2033 年

2024年，日本精准医疗市场规模达48.55亿美元。展望未来， IMARC Group预计到2033年市场规模将达到73.74亿美元，2025-2033年期间的成长率（CAGR）为4.8%。远距医疗和远端监控技术的需求不断增长，这主要推动着市场的发展，这些技术可以持续收集和分析资料，从而使医疗保健提供者能够根据个人患者的资料即时调整治疗计划。

精准医疗是指一种创新的医疗保健方法，根据患者独特的环境、遗传和生活方式因素，为其量身定制医疗和干预措施。与传统的「一刀切」方法不同，精准医疗认识到每个人的基因组成和生活环境都是不同的。透过分析一个人的基因图谱和其他相关资料，医疗保健提供者可以做出更准确的诊断，预测疾病风险并制定个人化治疗计划。这种方法不仅可以使治疗更有效，而且可能更安全，因为它可以最大限度地减少副作用。精准医疗在肿瘤学等各个医学领域显示出良好的效果，其中可以设计针对性疗法来专门对抗癌细胞，同时保护健康组织。它还可应用于心臟病学、神经病学和精神病学等领域，帮助优化从心臟病到精神疾病等各种疾病的治疗。精准医疗的最终目标是透过提供客製化、高效、以患者为中心的解决方案来改善治疗结果和生活质量，从而彻底改变医疗保健。

日本精准医疗市场趋势：

日本精准医疗在医疗健康领域发展动能快速。有多种因素推动着其成长。首先，基因组学和生物技术的进步为更深入了解疾病的遗传基础铺平了道路。这些知识促进了有针对性的治疗的发展，从而改善了患者的治疗效果。此外，日本慢性病发生率的上升也是一个重要驱动因素。精准医疗有望提供更有效的治疗和更好的疾病管理，从而有可能减轻医疗保健系统的负担。此外，政府对精准医疗研发的措施和资金支持也扮演关键角色。政策制定者认识到精准医疗在降低医疗成本和改善病患照护方面的潜力，从而增加了对该领域的投资。除此之外，巨量资料和高级分析工具的广泛应用，结合电子健康记录、基因组资料和临床信息，可以提供更精确的诊断和治疗建议，预计将在预测期内推动日本的精准医疗发展。

日本精准医疗市场细分：

产品洞察：

• 耗材
• 仪器
• 服务

技术洞察：

• 大数据分析
• 生物资讯学
• 基因定序
• 药物研发
• 伴随诊断
• 其他的

应用程式洞察：

• 肿瘤学
• 中枢神经系统（CNS）
• 免疫学
• 呼吸内科
• 感染
• 其他的

最终用户洞察：

• 医院和诊所
• 诊断中心
• 製药和生物技术公司
• 医疗保健IT公司
• 其他的

竞争格局：

市场研究报告也对市场竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、顶级制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

• 日本精准医疗市场目前表现如何？未来几年将如何表现？
• 新冠疫情对日本精准医疗市场有何影响？
• 日本精准医疗市场依产品划分是怎样的？
• 日本精准医疗市场依技术分類的分布如何？
• 日本精准医疗市场按应用分類的分布如何？
• 根据最终用户，日本精准医疗市场是如何分類的？
• 日本精准医疗市场的价值链分为哪些阶段？
• 日本精准医疗的关键驱动因素和挑战是什么？
• 日本精准医疗市场的结构是怎么样的？主要参与者有哪些？
• 日本精准医疗市场的竞争程度如何？

本报告回答的关键问题：

• 日本精准医疗市场目前表现如何？未来几年将如何表现？
• 新冠疫情对日本精准医疗市场有何影响？
• 日本精准医疗市场依产品划分是怎样的？
• 日本精准医疗市场依技术分類的分布如何？
• 日本精准医疗市场按应用分類的分布如何？
• 根据最终用户，日本精准医疗市场是如何分類的？
• 日本精准医疗市场的价值链分为哪些阶段？
• 日本精准医疗的关键驱动因素和挑战是什么？
• 日本精准医疗市场的结构是怎么样的？主要参与者有哪些？
• 日本精准医疗市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

• 研究目标
• 利害关係人
• 资料来源
  • 主要来源
  • 次要来源
• 市场评估
  • 自下而上的方法
  • 自上而下的方法
• 预测方法

第三章：执行摘要

第四章：日本精准医疗市场－简介

• 概述
• 市场动态
• 产业趋势
• 竞争情报

第五章：日本精准医疗市场格局

• 历史与当前市场趋势（2019-2024）
• 市场预测（2025-2033）

第六章：日本精准医疗市场-细分：依产品

• 耗材
  • 概述
• 仪器
  • 概述
• 服务
  • 概述

第七章：日本精准医疗市场-细分：依技术

• 大数据分析
  • 概述
• 生物资讯学
  • 概述
• 基因定序
  • 概述
• 药物研发
  • 概述
• 伴随诊断
  • 概述
• 其他的

第 8 章：日本精准医疗市场 - 细分：按应用

• 肿瘤学
  • 概述
• 中枢神经系统（CNS）
  • 概述
• 免疫学
  • 概述
• 呼吸内科
  • 概述
• 感染
  • 概述
• 其他的

第九章：日本精准医疗市场-细分：依最终用户

• 医院和诊所
  • 概述
• 诊断中心
  • 概述
• 製药和生物技术公司
  • 概述
• 医疗保健IT公司
  • 概述
• 其他的

第十章：日本精准医疗市场－竞争格局

• 概述
• 市场结构
• 市场参与者定位
• 最佳获胜策略
• 竞争仪錶板
• 公司评估象限

第 11 章：关键参与者简介

• Company A
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company B
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company C
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company D
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company E
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events

第十二章：日本精准医疗市场-产业分析

• 驱动因素、限制因素和机会
  • 概述
  • 驱动程式
  • 限制
  • 机会
• 波特五力分析
  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁
• 价值链分析

第 13 章：附录

Japan precision medicine market size reached USD 4,855 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 7,374 Million by 2033, exhibiting a growth rate (CAGR) of 4.8% during 2025-2033. The increasing demand for telemedicine and remote monitoring technologies, which allow for continuous data collection and analysis, thereby enabling healthcare providers to make real-time adjustments to treatment plans based on individual patient data, is primarily driving the market.

Precision medicine refers to an innovative healthcare approach that tailors medical treatment and interventions to individual patients based on their unique environmental, genetic, and lifestyle factors. Unlike traditional one-size-fits-all approaches, precision medicine recognizes that each person's genetic makeup and life circumstances are distinct. By analyzing a person's genetic profile and other relevant data, healthcare providers can make more accurate diagnoses, predict disease risk, and personalize treatment plans. This approach allows for treatments that are not only more effective but also potentially safer, as they minimize adverse effects. Precision medicine has shown promising results in various medical fields, such as oncology, where targeted therapies can be designed to specifically combat cancer cells while sparing healthy tissue. It also has applications in areas like cardiology, neurology, and psychiatry, helping to optimize treatments for ailments ranging from heart disease to mental health disorders. Ultimately, precision medicine aims to revolutionize healthcare by delivering tailored, efficient, and patient-centered solutions that improve outcomes and quality of life.

Japan Precision Medicine Market Trends:

The precision medicine in Japan is rapidly gaining momentum in the healthcare industry. Several drivers are propelling its growth. Firstly, advancements in genomics and biotechnology have paved the way for a deeper understanding of the genetic basis of diseases. This knowledge has enabled the development of targeted therapies, leading to improved patient outcomes. Moreover, the increasing incidence of chronic diseases in Japan is a significant driver. Precision medicine offers the promise of more efficacious treatments and better disease management, potentially reducing the burden on healthcare systems. Additionally, government initiatives and funding support for precision medicine R&D are playing a pivotal role. Policymakers recognize the potential of precision medicine to reduce healthcare costs and improve patient care, leading to increased investments in this field. Apart from this, the inflating application of big data and advanced analytics tools with the integration of electronic health records, genomic data, and clinical information that allow for more precise diagnosis and treatment recommendations is expected to drive the precision medicine in Japan during the forecast period.

Japan Precision Medicine Market Segmentation:

Product Insights:

• Consumables
• Instruments
• Services

Technology Insights:

• Big Data Analytics
• Bioinformatics
• Gene Sequencing
• Drug Discovery
• Companion Diagnostics
• Others

Application Insights:

• Oncology
• Central Nervous System (CNS)
• Immunology
• Respiratory Medicine
• Infections
• Others

End User Insights:

• Hospitals and Clinics
• Diagnostic Centers
• Pharma and Biotech Companies
• Healthcare IT Firms
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan precision medicine market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan precision medicine market?
• What is the breakup of the Japan precision medicine market on the basis of product?
• What is the breakup of the Japan precision medicine market on the basis of technology?
• What is the breakup of the Japan precision medicine market on the basis of application?
• What is the breakup of the Japan precision medicine market on the basis of end user?
• What are the various stages in the value chain of the Japan precision medicine market?
• What are the key driving factors and challenges in the Japan precision medicine?
• What is the structure of the Japan precision medicine market and who are the key players?
• What is the degree of competition in the Japan precision medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Precision Medicine Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Precision Medicine Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Precision Medicine Market - Breakup by Product

• 6.1 Consumables
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Instruments
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Services
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)

7 Japan Precision Medicine Market - Breakup by Technology

• 7.1 Big Data Analytics
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Bioinformatics
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Gene Sequencing
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Drug Discovery
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)
• 7.5 Companion Diagnostics
  • 7.5.1 Overview
  • 7.5.2 Historical and Current Market Trends (2019-2024)
  • 7.5.3 Market Forecast (2025-2033)
• 7.6 Others
  • 7.6.1 Historical and Current Market Trends (2019-2024)
  • 7.6.2 Market Forecast (2025-2033)

8 Japan Precision Medicine Market - Breakup by Application

• 8.1 Oncology
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Central Nervous System (CNS)
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Immunology
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)
• 8.4 Respiratory Medicine
  • 8.4.1 Overview
  • 8.4.2 Historical and Current Market Trends (2019-2024)
  • 8.4.3 Market Forecast (2025-2033)
• 8.5 Infections
  • 8.5.1 Overview
  • 8.5.2 Historical and Current Market Trends (2019-2024)
  • 8.5.3 Market Forecast (2025-2033)
• 8.6 Others
  • 8.6.1 Historical and Current Market Trends (2019-2024)
  • 9.6.2 Market Forecast (2025-2033)

9 Japan Precision Medicine Market - Breakup by End User

• 9.1 Hospitals and Clinics
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2019-2024)
  • 9.1.3 Market Forecast (2025-2033)
• 9.2 Diagnostic Centers
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2019-2024)
  • 9.2.3 Market Forecast (2025-2033)
• 9.3 Pharma and Biotech Companies
  • 9.3.1 Overview
  • 9.3.2 Historical and Current Market Trends (2019-2024)
  • 9.3.3 Market Forecast (2025-2033)
• 9.4 Healthcare IT Firms
  • 9.4.1 Overview
  • 9.4.2 Historical and Current Market Trends (2019-2024)
  • 9.4.3 Market Forecast (2025-2033)
• 9.5 Others
  • 9.5.1 Historical and Current Market Trends (2019-2024)
  • 9.5.2 Market Forecast (2025-2033)

10 Japan Precision Medicine Market - Competitive Landscape

• 10.1 Overview
• 10.2 Market Structure
• 10.3 Market Player Positioning
• 10.4 Top Winning Strategies
• 10.5 Competitive Dashboard
• 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

• 11.1 Company A
  • 11.1.1 Business Overview
  • 11.1.2 Product Portfolio
  • 11.1.3 Business Strategies
  • 11.1.4 SWOT Analysis
  • 11.1.5 Major News and Events
• 11.2 Company B
  • 11.2.1 Business Overview
  • 11.2.2 Product Portfolio
  • 11.2.3 Business Strategies
  • 11.2.4 SWOT Analysis
  • 11.2.5 Major News and Events
• 11.3 Company C
  • 11.3.1 Business Overview
  • 11.3.2 Product Portfolio
  • 11.3.3 Business Strategies
  • 11.3.4 SWOT Analysis
  • 11.3.5 Major News and Events
• 11.4 Company D
  • 11.4.1 Business Overview
  • 11.4.2 Product Portfolio
  • 11.4.3 Business Strategies
  • 11.4.4 SWOT Analysis
  • 11.4.5 Major News and Events
• 11.5 Company E
  • 11.5.1 Business Overview
  • 11.5.2 Product Portfolio
  • 11.5.3 Business Strategies
  • 11.5.4 SWOT Analysis
  • 11.5.5 Major News and Events

12 Japan Precision Medicine Market - Industry Analysis

• 12.1 Drivers, Restraints and Opportunities
  • 12.1.1 Overview
  • 12.1.2 Drivers
  • 12.1.3 Restraints
  • 12.1.4 Opportunities
• 12.2 Porters Five Forces Analysis
  • 12.2.1 Overview
  • 12.2.2 Bargaining Power of Buyers
  • 12.2.3 Bargaining Power of Suppliers
  • 12.2.4 Degree of Competition
  • 12.2.5 Threat of New Entrants
  • 12.2.6 Threat of Substitutes
• 12.3 Value Chain Analysis

13 Appendix